Skip to Main Content
Contribute Try STAT+ Today

Before she accepted a recent offer to become chief executive of Alnylam Pharmaceuticals, Yvonne Greenstreet consulted two women she respects, her mother and her daughter.

Miranda Greenstreet, 88, is from the West African nation of Ghana and often blazed trails, her daughter said. She married a white Englishman whom she met in the 1950s when they were students at the London School of Economics. Later, she set up an institute that promoted adult literacy in Ghana. When Yvonne Greenstreet called to ask if she should take the job, she recalled, her mother didn’t hesitate, saying, “Is there a choice?”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment